Abstract
The objective of this study was to describe the outcome of allogeneic stem cell transplantation (alloSCT) in a series of patients with B cell chronic lymphocytic leukemia (B-CLL). Twenty-three B-CLL patients were transplanted between 1988 and 1997 using stem cells from a related (n = 20) or an unrelated donor (n = 3). The median age of the patients was 46 years, and the median number of prior chemotherapy regimens received was two. At transplantation, 14 patients had chemorefractory disease and 12 of these were refractory to fludarabine. The preparative regimens included total body irradiation (TBI) in 22 of the 23 cases. All patients received graft-versus-host disease (GVHD) prophylaxis with cyclosporine and methotrexate. Twenty patients (87%) achieved a complete remission (CR). The incidence of grade II–IV acute GVHD was 54%. Fourteen (61%) patients are alive and disease-free, including two with unrelated donors, at a median of 26 months (range, 9–115 months). Nine patients (39%) have died, one of whom had progressive B-CLL. The only favorable prognostic factor for failure-free survival (FFS) and overall survival (OS) after alloSCT was the use of a cyclophosphamide/TBI rather than an etoposide/ cyclophosphamide/TBI regimen (P = 0.03). The projected 5-year FFS, OS, and relapse rates after alloSCT were 65% (95% CI, 48–88%), 62% (95% CI, 43–88%), and 5% (95%, CI 0–13%), respectively. These findings demonstrate the potential of high-dose therapy and alloSCT for inducing and maintaining a remission in patients with advanced or chemorefractory B-CLL. The low relapse rate may be due to an allogeneic graft-versus-leukemia effect. Bone Marrow Transplantation (2000) 25, 717–722.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rozman C, Montserrat E . Chronic lymphocytic leukemia New Engl J Med 1995 333: 1052–1057
Keating MJ, O'Brien S, Kantarjian H et al. Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent Blood 1993 81: 2878–2884
Montserrat E, Gomis F, Vallespi T et al. Presenting features and prognosis of chronic lymphocytic leukemia in younger adults Blood 1991 78: 1545–1551
Pavletic ZS, Bierman PJ, Vose JM et al. High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma Ann Oncol 1998 9: 1023–1026
Khouri IF, Keating MJ, Vriesendorp HM et al. Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results J Clin Oncol 1994 12: 748–758
Khouri IF, Reading C, Vriesendorp HM et al. High-dose cyclophosphamide, total body irradiation and autologous bone marrow transplantation for chronic lymphocytic leukemia. In: Dicke KA, Keating A (eds). Autologous Marrow and Blood Transplantation, Proceedings of the Seventh International Symposium The Cancer Treatment Research Center and Educational Institute: Arlington 1995 pp219–227
Armitage JO . Bone marrow transplantation New Engl J Med 1994 330: 827–838
Rabinowe SN, Soiffer RJ, Gribben JG et al. Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia Blood 1993 82: 1366–1376
Michallet M, Archimbaud E, Bandini G et al. HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia Ann Intern Med 1996 124: 311–315
Esteve J, Villamor N, Colomer D et al. Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: a report of 12 patients from a single institution Ann Oncol 1998 9: 167–172
Martinez C, Martino R, Brunet S et al. Allogeneic stem cell transplantation for advanced low-grade lymphoproliferative disorders: report of six cases Hematologica 1996 81: 330–334
Khouri IF, Przepiorka D, van Besien K et al. Allogeneic blood or marrow transplantation for chronic lymphocytic leukemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease Br J Haematol 1997 97: 466–473
Bierman PJ, Warkentin P, Hutchins MR, Klassen LW . Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocytic leukemia: response to antithymocyte globulin Leuk Lymphoma 1993 9: 169–171
Cheson BD, Bennett JM, Grever M et al. Guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment: NCI-sponsored working group Blood 1996 87: 4990–4997
Pavletic ZS, Bishop MR, Tarantolo SR et al. Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies J Clin Oncol 1997 15: 1608–1616
Stein RS, Greer JP, Goodman S et al. High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin Bone Marrow Transplant 1999 23: 227–233
Suttorp M, Schmitz N, Dreger P et al. Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms Leukemia 1993 7: 679–687
Sullivan KM . Graft-versus-host disease. In: Forman SJ, Blume KG, Thomas ED (eds) Bone Marrow Transplantation Blackwell Scientific: Boston, MA 1994 pp339–362
Thomas ED, Lochte HL, Lu WC et al. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy New Engl J Med 1957 157: 491–496
Mehta J, Powles R, Sinhgal S et al. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia Bone Marrow Transplant 1996 17: 371–375
Rondon G, Giralt S, Huh Y et al. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia Bone Marrow Transplant 1996 18: 669–672
Jarque I, Palau J, Sanz GF et al. Delayed complete response after allogeneic bone marrow transplantation in chronic lymphocytic leukemia (letter) Blood 1993 82: 1035–1038
Keating MJ, O'Brien S, Lerner S et al. Treatment of chronic lymphocytic leukemia after failure or relapse on fludarabine regimens Blood 1996 88: 588a (Abstr.)
van Besien K, Sobocinski KA, Rowlings PA et al. Allogeneic bone marrow transplantation for low-grade lymphoma Blood 1998 92: 1832–1836
Khouri IF, Keating MK, Korbling M et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment of lymphoid malignancies J Clin Oncol 1998 16: 2817–2824
McSweeney PA, Wagner JL, Maloney DG et al. Outpatient PBSC allografts using immunosuppression with low-dose TBI before and cyclosporine and mycophenolate mofetil after transplant Blood 1998 92: 518a (Abstr.)
Gribben JG, Neuberg D, Soiffer RJ et al. Autologous versus allogeneic bone marrow transplantation for patients with poor prognosis CLL Blood 1998 92: 322a (Abstr.)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pavletic, Z., Arrowsmith, E., Bierman, P. et al. Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia. Bone Marrow Transplant 25, 717–722 (2000). https://doi.org/10.1038/sj.bmt.1702237
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702237
Keywords
This article is cited by
-
A scoping review of caregiver burden during allogeneic HSCT: lessons learned and future directions
Bone Marrow Transplantation (2016)
-
Pushing the envelope—nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation
Bone Marrow Transplantation (2015)
-
Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors
Leukemia (2014)
-
Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome
Leukemia (2013)
-
High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse
Medical Oncology (2013)